These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4741388)

  • 21. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411
    [No Abstract]   [Full Text] [Related]  

  • 22. Prevalence survey of secondary dapsone resistance in leprosy in Kancheepuram and Tiruvannamalai control units of Tamil Nadu.
    Neelan PN; Noordeen SK; Balakrishnan S; Pandian PR
    Lepr India; 1983 Apr; 55(2):222-30. PubMed ID: 6355650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary sulphone resistance in leprosy (Report of a case).
    Lal S; Jaganath C; Garg BR; Paneerselvam R
    Lepr India; 1980 Apr; 52(2):299-301. PubMed ID: 7005542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Survey on the prevalence rate of dapsone-resistant leprosy in the Yangzhou district].
    Li WZ; Ye GY; Wang HY; Tao MB; Ma B; Zhang YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Feb; 6(1):59-61. PubMed ID: 6238701
    [No Abstract]   [Full Text] [Related]  

  • 25. Dapsone resistance in patients attending Central Leprosy Teaching and Research Institute, Chengalpattu (South India).
    Bhatia VN; Balakrishnan S; Seshadri PS; Neelan PN; Roy RG
    Indian J Lepr; 1984; 56(3):587-94. PubMed ID: 6396340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on sulfone resistance in leprosy. 3. A case of "partial" resistance.
    Pearson JM; Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1968; 36(2):171-8. PubMed ID: 4877115
    [No Abstract]   [Full Text] [Related]  

  • 27. [Secondary dapsone resistance in leprotic patients of the Shanghai district].
    Ji BH
    Zhonghua Yi Xue Za Zhi; 1983 Apr; 63(4):244-7. PubMed ID: 6413025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Results of animal experimentation activities at the Institut Marchoux in Bamako (1982-1984)].
    Traore I; Nebout M
    Acta Leprol; 1985; 3(3):255-9. PubMed ID: 3909721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Co-incident (simultaneous) dapsone sensitivity and dapsone-resistant leprosy.
    Pettit JH
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):258-9. PubMed ID: 6684650
    [No Abstract]   [Full Text] [Related]  

  • 30. The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea.
    Lee SB; Kim SK; Kang TJ; Chae GT; Chun JH; Shin HK; Kim JP; Ko YH; Kim NH
    Ann Trop Med Parasitol; 2001 Jun; 95(4):429-32. PubMed ID: 11454253
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of leprosy.
    Ramanujam K
    J Indian Med Assoc; 1973 Nov; 61(9):401-2. PubMed ID: 4791935
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Dapsone dosage and drug resistance.
    Pfaltzgraff RE
    Lepr Rev; 1975 Sep; 46(3):235-8. PubMed ID: 1186417
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
    Peters JH; Gordon GR; Levy L; Strokan MA; Jacobson RR; Enna CD; Kirchheimer WF
    Am J Trop Med Hyg; 1974 Mar; 23(2):222-30. PubMed ID: 4817667
    [No Abstract]   [Full Text] [Related]  

  • 34. [Histoid leprosy: clinical and experimental observations (author's transl)].
    Li WZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Mar; 3(1):23-6. PubMed ID: 6458388
    [No Abstract]   [Full Text] [Related]  

  • 35. Primary dapsone-resistant leprosy in Republic of Korea.
    Matsuo Y; Tatsukawa H; Kim DI; Hah YM
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):510. PubMed ID: 6892027
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug resistance in Nepali leprosy patients.
    Butlin CR; Neupane KD; Failbus SS; Morgan A; Britton WJ
    Int J Lepr Other Mycobact Dis; 1996 Jun; 64(2):136-41. PubMed ID: 8690972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further results on dapsone-resistant leprosy in Bamako (Mali).
    Baquillon G; Ferracci C; van Loo G; Pattyn SR
    Lepr Rev; 1983 Mar; 54(1):19-21. PubMed ID: 6843273
    [No Abstract]   [Full Text] [Related]  

  • 38. Dapsone-resistant leprosy in Addis Ababa: a progress report.
    Warndorff van Diepen T; Aredath SP; Mengistu G
    Lepr Rev; 1984 Jun; 55(2):149-57. PubMed ID: 6748846
    [No Abstract]   [Full Text] [Related]  

  • 39. The problem of dapsone-resistant leprosy: diagnosis and management.
    Laing AB
    Int J Dermatol; 1981 May; 20(4):275-7. PubMed ID: 7239747
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the study of the leprosy bacillus.
    Rees RJ
    Sci Basis Med Annu Rev; 1969; ():320-35. PubMed ID: 4917843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.